| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.79B | — | -6.1% |
| Cost of Revenue | $9.15B | — | -6.2% |
| R&D Expense | $181.0M | — | -9.5% |
| SG&A Expense | $417.0M | — | +13.9% |
| Interest Expense | $219.0M | — | +1.4% |
| Pre-tax Income | -$390.0M | — | -4.3% |
| Income Tax | $55.0M | — | +165.5% |
| Net Income | -$533.0M | — | -73.6% |
| EPS (Basic) | -$0.74 | — | -68.2% |
| EPS (Diluted) | -$0.74 | — | -68.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.11B | +7.7% | +180.5% |
| Accounts Receivable | $5.18B | +8.9% | +5.5% |
| Inventory | $6.78B | +2.7% | +0.1% |
| Current Assets | $19.47B | +7.8% | +19.2% |
| Total Assets | $59.78B | +2.1% | +4.0% |
| Current Liabilities | $10.54B | +14.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.12B | — | +1135.2% |
| Investing Cash Flow | -$448.0M | — | -11.7% |
| Financing Cash Flow | -$320.0M | — | +38.6% |
| -0.5% |
| Long-term Debt | $17.25B | -3.3% | +8.3% |
| Stockholders' Equity | $15.25B | -4.7% | -9.2% |